We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
 

Latest News

Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test
News   Nov 29, 2011

Companion diagnostic tests identify specific DNA sequences for cancer immunotherapy antigen.

READ MORE

Informatics Student Implements Real World Cancer Research
News   Nov 29, 2011

Alexis Christoforides, a first year Ph.D. candidate at Arizona State University’s Department of Biomedical Informatics, and full-time employee at the Translational Genomics Institute (TGen), renders class work to real world application.

READ MORE

Cancer stem cells: Prime targets in the war against cancer
News   Nov 28, 2011

Scientists now believe that only a small subset of cells in a tumour has the ability to self-renew and differentiate indefinitely into other cells – these are known as cancer stem cells (CSC) due to their stem-like qualities.

READ MORE

UT Southwestern Team Identifies Tumor-specific Pathway
News   Nov 28, 2011

Finding could lead to new cancer-stopping therapies.

READ MORE

Horizon Announces Collaboration with NCI and NHGRI
News   Nov 24, 2011

Horizon’s rAAV gene targeting to be applied in cancer research programs, enabling the NCI and NHGRI to engineer human isogenic disease models.

READ MORE

Geron to Focus on its Novel Cancer Programs
News   Nov 21, 2011

Geron Corporation has announced that they will be focusing on first-in-class oncology programs. As a consequence, the Company will discontinue further development of its stem cell programs and is seeking partners for these novel assets.

READ MORE

Key Patents Issued to Celerus Diagnostics
News   Nov 21, 2011

Company Secures Long-term Control of Rapid IHC® Technologies

READ MORE

High-Throughput Targeted Sequencing of Cancer Predisposition Genes
News   Nov 18, 2011

British Columbia Cancer Agency selects Raindance’s new ThunderStorm System to aid researchers in hereditary cancer testing, using next-generation sequencing.

READ MORE

MethylGene Reports Clinical Data for MGCD265
News   Nov 17, 2011

Data to be presented at the 2011 AACR-NCI- EORTC Molecular Targets and Cancer Therapeutics Conference.

READ MORE

Stage II Colon Cancer Recurrence Signature Published in the Journal of Clinical Oncology
News   Nov 15, 2011

The article entitled “Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue” gives detail on the development and validation of a prognostic gene signature in Stage II colon cancer.

READ MORE

 
Advertisement